15-22786671-TGCGGCAGCGGCGGCGGCG-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP3BS2
The NM_144599.5(NIPA1):βc.21_38delβ(p.Ala11_Ala16del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000178 in 1,065,912 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.000065 ( 0 hom., cov: 6)
Exomes π: 0.000011 ( 0 hom. )
Consequence
NIPA1
NM_144599.5 inframe_deletion
NM_144599.5 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.80
Genes affected
NIPA1 (HGNC:17043): (NIPA magnesium transporter 1) This gene encodes a magnesium transporter that associates with early endosomes and the cell surface in a variety of neuronal and epithelial cells. This protein may play a role in nervous system development and maintenance. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene have been associated with autosomal dominant spastic paraplegia 6. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_144599.5
BS2
High AC in GnomAd4 at 9 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NIPA1 | NM_144599.5 | c.21_38del | p.Ala11_Ala16del | inframe_deletion | 1/5 | ENST00000337435.9 | |
NIPA1 | NM_001142275.1 | c.-48+429_-48+446del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NIPA1 | ENST00000337435.9 | c.21_38del | p.Ala11_Ala16del | inframe_deletion | 1/5 | 1 | NM_144599.5 | P1 | |
NIPA1 | ENST00000437912.6 | c.-48+12364_-48+12381del | intron_variant | 1 | |||||
NIPA1 | ENST00000561183.5 | c.-48+429_-48+446del | intron_variant | 1 | |||||
NIPA1 | ENST00000560069.5 | n.31+429_31+446del | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000648 AC: 9AN: 138958Hom.: 0 Cov.: 6
GnomAD3 genomes
AF:
AC:
9
AN:
138958
Hom.:
Cov.:
6
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000108 AC: 10AN: 926954Hom.: 0 AF XY: 0.0000135 AC XY: 6AN XY: 443684
GnomAD4 exome
AF:
AC:
10
AN:
926954
Hom.:
AF XY:
AC XY:
6
AN XY:
443684
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000648 AC: 9AN: 138958Hom.: 0 Cov.: 6 AF XY: 0.0000891 AC XY: 6AN XY: 67372
GnomAD4 genome
AF:
AC:
9
AN:
138958
Hom.:
Cov.:
6
AF XY:
AC XY:
6
AN XY:
67372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 6 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with NIPA1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant, c.21_38del, results in the deletion of 6 amino acid(s) of the NIPA1 protein (p.Ala11_Ala16del), but otherwise preserves the integrity of the reading frame. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 04, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at